- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05728034
Information Seeking About Pre-exposure Prophylaxis
Information Seeking About Pre-exposure Prophylaxis Among Men Who Have Sex With Men
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study 1 (online between-subjects experiment): An online sample of YMSM (N = 600) will be strategically recruited to partake in a web-based survey experiment following a mixed experimental design: 2 (PrEP type [between]: oral or injectable PrEP) X 5 (messaging strategy [within]: response efficacy, social norms, exemplar, celebrity, & basic information). The survey will begin by determining eligibility (self-report screener questions), gathering consent, and asking participants to self-report on several psychographic measures (PrEP awareness, knowledge, interest, and stigma). Participants will then be asked to interact with a mock Google results page featuring an array of information about PrEP. The survey will randomly assign participants to one of two versions of the mock Google search page: Half of participants (n = 300) will browse for information about oral PrEP, and the other half (n = 300) will browse for information about injectable PrEP. This browsing experience will unobtrusively log browsing data (clicks, page durations). Participants will be able to click on the links on the search results page (which reflect the five messaging strategies), visit those pages, and return to the main results page. After three minutes, participants will then be asked to self-report their intention to adopt PrEP. They will then be debriefed.
Study 2 (in-person within-subjects experiment): Interested participants will complete an initial screening questionnaire to ensure eligibility and then be linked to a separate survey to provide their contact information. Upon arrival to the study site, participants (N = 75) will begin by providing consent. They will then complete the same measures as Study 1 of PrEP interest, knowledge, and stigma. A research assistant will lead participants through a calibration activity to ensure the eye-trackers are able to track the participants' eye gaze. Participants will complete the same mock browsing experience as Study 1 with the exception that all participants will browse for information about injectable PrEP. The survey software will unobtrusively log browsing behavior (clicks, page durations) while eye-trackers will unobtrusively track visual behavior (fixations). Participants will then self-report their intent to use PrEP and be debriefed by a research assistant,
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christofer J Skurka, PhD
- Phone Number: 814-863-1482
- Email: cjs7142@psu.edu
Study Contact Backup
- Name: Jessica Myrick, PhD
- Phone Number: 814-863-0535
- Email: jgm43@psu.edu
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Recruiting
- Pennsylvania State University
-
Contact:
- Christofer Skurka, PhD
- Phone Number: 814-863-1482
- Email: cjs7142@psu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Have an Internet-connectable device (Study 1 only)
- Be 18-34 years of age
- Identify as cisgender male
- Identify as gay or bisexual
- Be HIV negative
- Have had anal sex in the past 6 months
- Meet one of the following criteria: a. Have a sexual partner with HIV, b. Have inconsistent condom use, c. Have received an STI diagnosis in the last 6 months.
Exclusion Criteria:
- Does not meet all of the criteria above
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Injectable PrEP information
A mock Google search results page with five search results that reflect five messaging strategies about injectable PrEP (response efficacy, social norms, exemplar, celebrity, and basic information), displayed in random order.
|
Participants will be able to click on the links on the search results page (which reflect the five messaging strategies about injectable PrEP), visit those pages, and return to the main results page.
|
Experimental: Oral PrEP information (Study 1 only)
A mock Google search results page with five search results that reflect five messaging strategies about oral PrEP (response efficacy, social norms, exemplar, celebrity, and basic information), displayed in random order.
|
Participants will be able to click on the links on the search results page (which reflect the five messaging strategies about oral PrEP), visit those pages, and return to the main results page.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Browsing behavior - First click
Time Frame: Recorded while participants complete the Google results browsing task (3 minutes max)
|
SoSciSurvey software will unobtrusively log the clicks participants will make on the different search results, with each search result reflecting a different messaging strategy (response efficacy, social norms, exemplar, celebrity, and basic information).
Our analysis will focus on which search result/messaging strategy participants click on first as a behavioral indicator of message engagement.
|
Recorded while participants complete the Google results browsing task (3 minutes max)
|
Browsing behavior - Total page duration
Time Frame: Recorded while participants complete the Google results browsing task (3 minutes max)
|
SoSciSurvey software will unobtrusively log the amount of time (in seconds) participants spend on the different search results after clicking on it, with each search result reflecting a different messaging strategy (response efficacy, social norms, exemplar, celebrity, and basic information).
Our analysis will focus on the total amount of time participants spend on the page for each of the different search results/messaging strategies as a behavioral indicator of message engagement.
|
Recorded while participants complete the Google results browsing task (3 minutes max)
|
Visual behavior - Total fixation duration (Study 2 only)
Time Frame: Recorded while participants complete the Google results browsing task (3 minutes max)
|
Total fixation duration can be defined as how long the eyes dwell on a particular object in one's field of vision.
Total fixation duration will be recorded by mobile eye-trackers.
|
Recorded while participants complete the Google results browsing task (3 minutes max)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in intention to adopt PrEP
Time Frame: Will be measured immediately after completing the browsing task
|
Self-reported change in intention to initiate PrEP, assessed on a 0-100 sliding scale (0 = definitely not, 100 = definitely yes).
Thus, higher scores reflect greater intentions to use PrEP.
|
Will be measured immediately after completing the browsing task
|
Open-ended responses
Time Frame: Will be measured immediately after completing the browsing task
|
Participants will be given an opportunity to list any other thoughts and suggestions they have about the kinds of messaging strategies about injectable PrEP that might engage their attention.
|
Will be measured immediately after completing the browsing task
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christofer J Skurka, PhD, Penn State University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00021859
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pre-exposure Prophylaxis
-
Fenway Community HealthHarvard UniversityCompletedPre-Exposure ProphylaxisUnited States
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)RecruitingSex Work | Pre-Exposure ProphylaxisUnited States
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID); AIDS Healthcare...RecruitingSTI | Contraceptive Usage | Pre-Exposure ProphylaxisSouth Africa
-
Medstar Health Research InstituteCompletedPre-Exposure ProphylaxisUnited States
-
Indiana UniversityCompletedPre-Exposure ProphylaxisUnited States
-
George Washington UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Gilead SciencesCompletedPre-Exposure ProphylaxisUnited States
-
Beth Israel Deaconess Medical CenterNational Institute of Mental Health (NIMH); The Fenway InstituteCompleted
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV | Pre-exposure ProphylaxisChina
-
Johns Hopkins UniversityGilead SciencesCompletedPre-Exposure Prophylaxis (PrEP)United States
-
University Hospital, Clermont-FerrandCompletedPre-exposure HIV Prophylaxis (PrEP)France
Clinical Trials on Injectable PrEP information
-
Brown UniversityNational Institute on Drug Abuse (NIDA); University of California, San Diego; Beth Israel Deaconess Medical Center and other collaboratorsRecruitingSubstance Dependence | HIV (Human Immunodeficiency Virus)United States
-
University of WashingtonKenyatta National Hospital; Fogarty International Center of the National Institute...Active, not recruitingPrEP Uptake | HIV Antibody PositivityKenya
-
Hunter College of City University of New YorkNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Gilead SciencesCompletedHuman Immunodeficiency Virus (HIV)United States
-
University of UlsterNorthern Ireland Chest Heart and StrokeCompleted
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Kenyatta National...Completed
-
San Diego State UniversityNational Institute of Mental Health (NIMH); Hennepin Healthcare Research InstituteCompleted
-
Hilary L Surratt, PhDNational Institute on Drug Abuse (NIDA)CompletedHIV PreventionUnited States
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)RecruitingSex Work | Pre-Exposure ProphylaxisUnited States
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPregnancy Related | HIV Prevention | Pre-exposure ProphylaxisMalawi
-
University of Massachusetts, WorcesterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPre-Exposure ProphylaxisThailand